학술논문

발행년
-
(예 : 2010-2015)
'학술논문' 에서 검색결과 291건 | 목록 1~10
Electronic Resource
Teepen , JC , Kremer , LC , te Loo , M , Tissing , WJ , van der Pal , HJ , Van den Heuvel - Eibrink , M , Loonen , JJ , Louwerens , M , Versluys , B , van Dulmen-den Broeder , E , Visser , O , Maduro , JH , van Leeuwen , FE , Ronckers , CM , Bresters , D , Batenburg , L , Veening , M , Huizinga , G , van der Steeg , L , Jaspers , M , Vries , AC , Aleman , BMP , Caron , HN , Grootenhuis , MA , den Hartogh , JG , Hollema , N , Neggers , S J C M M , Postma , A , de Ridder-Sluiter , JG & Rutgers , EJT 2019 , ' Clinical characteristics and survival patterns of subsequent sarcoma, breast cancer, and melanoma after childhood cancer in the DCOG-LATER cohort ' , Cancer Causes & Control , vol. 30 , no. 9 , pp. 909-922 .
Academic Journal
Eleveld TF; Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands.; Department of Oncogenomics, Amsterdam UMC, Amsterdam, Netherlands.; Vernooij L; Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands.; Schild L; Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands.; Koopmans B; Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands.; Alles LK; Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands.; Ebus ME; Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands.; Dandis R; Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands.; van Tinteren H; Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands.; Caron HN; Hoffmann-La Roche, Basel, Switzerland.; Koster J; Department of Oncogenomics, Amsterdam UMC, Amsterdam, Netherlands.; van Noesel MM; Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands.; Tytgat GAM; Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands.; Eising S; Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands.; Versteeg R; Department of Oncogenomics, Amsterdam UMC, Amsterdam, Netherlands.; Dolman MEM; Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands.; Children's Cancer Institute, Lowy Cancer Centre, UNSW Sydney, Kensington, NSW, Australia.; School of Clinical Medicine, UNSW Medicine & Health, UNSW Sydney, Kensington, NSW, Australia.; Molenaar JJ; Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands.; Department of Pharmaceutical sciences, Utrecht University, Utrecht, Netherlands.
Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE
Academic Journal
Hurkmans EGE; Department of Human Genetics, Radboud University Medical Center, Nijmegen, Netherlands.; Klumpers MJ; Department of Pediatrics, Radboud University Medical Center, Nijmegen, Netherlands.; Dello Russo C; Department of Pharmacology and Therapeutics, Institute of Systems, Molecular and Integrative Biology (ISMIB), University of Liverpool, Liverpool, United Kingdom.; Department of Healthcare Surveillance and Bioethics, Section of Pharmacology, Università Cattolica del Sacro Cuore-Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.; De Witte W; Department of Human Genetics, Radboud University Medical Center, Nijmegen, Netherlands.; Guchelaar HJ; Department of Clinical Pharmacy & Toxicology, Leiden University Medical Center, Leiden, Netherlands.; Gelderblom H; Department of Medical Oncology, Leiden University Medical Center, Leiden, Netherlands.; Cleton-Jansen AM; Department of Pathology, Leiden University Medical Center, Leiden, Netherlands.; Vermeulen SH; Department for Health Evidence, Radboud University Medical Center, Nijmegen, Netherlands.; Kaal S; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, Netherlands.; van der Graaf WTA; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, Netherlands.; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, Netherlands.; Flucke U; Department of Pathology, Radboud University Medical Center, Nijmegen, Netherlands.; Gidding CEM; Princess Maxima Center for Pediatric Oncology, Utrecht, Netherlands.; Schreuder HWB; Department of Orthopedics, Radboud University Medical Center, Nijmegen, Netherlands.; de Bont ESJM; Department of Pediatrics, Beatrix Children's Hospital, University Medical Center Groningen, Groningen, Netherlands.; Caron HN; Department of Pediatrics, Amsterdam University Medical Centers, Emma Children's Hospital, Amsterdam, Netherlands.; Gattuso G; Pediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.; Schiavello E; Pediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.; Terenziani M; Pediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.; Massimino M; Pediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.; McCowage G; Cancer Centre for Children, The Children's Hospital at Westmead, Sydney, NSW, Australia.; Nagabushan S; Cancer Centre for Children, The Children's Hospital at Westmead, Sydney, NSW, Australia.; Discipline of Child and Adolescent Health, University of Sydney, Sydney, NSW, Australia.; Limaye A; Department of Audiology, The Children's Hospital at Westmead, Sydney, NSW, Australia.; Rose V; Department of Neuro-Otology, Royal Prince Alfred Hospital, University of Sydney, Sydney, NSW, Australia.; Catchpoole D; Children's Cancer Research Unit, The Children's Hospital at Westmead, Sydney, NSW, Australia.; Jorgensen AL; Department of Health Data Science, University of Liverpool, Liverpool, United Kingdom.; Barton C; Department of Women's and Children's Health, University of Liverpool, Liverpool, United Kingdom.; Delaney L; Department of Women's and Children's Health, University of Liverpool, Liverpool, United Kingdom.; Hawcutt DB; Department of Women's and Children's Health, University of Liverpool, Liverpool, United Kingdom.; NIHR Alder Hey Clinical Research Facility, Alder Hey Children's Hospital, Liverpool, United Kingdom.; Pirmohamed M; Department of Pharmacology and Therapeutics, University of Liverpool, Liverpool, United Kingdom.; Pizer B; Department of Pediatric Oncology, Alder Hey Children's Hospital, Liverpool, United Kingdom.; Coenen MJH; Department of Human Genetics, Radboud University Medical Center, Nijmegen, Netherlands.; Te Loo DMWM; Department of Pediatrics, Radboud University Medical Center, Nijmegen, Netherlands.
Publisher: Frontiers Media] Country of Publication: Switzerland NLM ID: 101548923 Publication Model: eCollection Cited Medium: Print ISSN: 1663-9812 (Print) Linking ISSN: 16639812 NLM ISO Abbreviation: Front Pharmacol Subsets: PubMed not MEDLINE
Academic Journal
Schubert NA; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Chen CY; Department of Pediatric Hematology and Oncology, Charité-Universitätsmedizin Berlin, Berlin, Germany.; Rodríguez A; Hoffman-La Roche, Basel, Switzerland.; Koster J; Department of Oncogenomics, Amsterdam University Medical Center, Amsterdam, the Netherlands.; Dowless M; Eli Lilly and Company, Indianapolis, IN, USA.; Pfister SM; Hopp Children's Cancer Center Heidelberg (KiTZ), German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK) and University Hospital, Heidelberg, Germany.; Shields DJ; Pfizer Centers for Therapeutic Innovation, Pfizer Inc., New York, NY, USA.; Stancato LF; Eli Lilly and Company, Indianapolis, IN, USA.; Vassal G; Institute Gustave Roussy, Université Paris Saclay, Villejuif, France.; Caron HN; Hoffman-La Roche, Basel, Switzerland.; van den Boogaard ML; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Henssen AG; Department of Pediatric Hematology and Oncology, Charité-Universitätsmedizin Berlin, Berlin, Germany; Berlin Institute of Health, Berlin, Germany; German Cancer Consortium (DKTK), Partner Site Berlin, And German Cancer Research Center (DKFZ), Heidelberg, Germany; Experimental and Clinical Research Center (ECRC) of the MDC and Charité Berlin, Berlin, Germany.; Molenaar JJ; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands; Department of Pharmaceutical Sciences, University Utrecht, Utrecht, Netherlands. Electronic address: j.j.molenaar@prinsesmaximacentrum.nl.
Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE
Academic Journal
Keller KM; Princess Máxima Center for Paediatric Oncology, Utrecht, the Netherlands.; Krausert S; Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany; Division of Paediatric Neurooncology, German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK), Heidelberg, Germany.; Gopisetty A; Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany; Division of Paediatric Neurooncology, German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK), Heidelberg, Germany.; Luedtke D; Eli Lilly and Company, Indianapolis, IN, USA.; Koster J; Department of Oncogenomics, Amsterdam University Medical Centre, Amsterdam, the Netherlands.; Schubert NA; Princess Máxima Center for Paediatric Oncology, Utrecht, the Netherlands.; Rodríguez A; Hoffman-La Roche, Basel, Switzerland.; van Hooff SR; Princess Máxima Center for Paediatric Oncology, Utrecht, the Netherlands.; Stichel D; Clinical Cooperation Unit Neuropathology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.; Dolman MEM; Princess Máxima Center for Paediatric Oncology, Utrecht, the Netherlands; Children's Cancer Institute, Lowy Cancer Centre, UNSW Sydney, Kensington, NSW, Australia; School of Women's and Children's Health, Faculty of Medicine, UNSW Sydney, NSW Australia.; Vassal G; Department of Clinical Research, Gustave Roussy, Villejuif, France.; Pfister SM; Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany; Division of Paediatric Neurooncology, German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK), Heidelberg, Germany; Department of Hematology and Oncology, Heidelberg University Hospital, Heidelberg, Germany.; Caron HN; Hoffman-La Roche, Basel, Switzerland.; Stancato LF; Eli Lilly and Company, Indianapolis, IN, USA.; Molenaar JJ; Princess Máxima Center for Paediatric Oncology, Utrecht, the Netherlands.; Jäger N; Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany; Division of Paediatric Neurooncology, German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK), Heidelberg, Germany.; Kool M; Princess Máxima Center for Paediatric Oncology, Utrecht, the Netherlands; Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany; Division of Paediatric Neurooncology, German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK), Heidelberg, Germany. Electronic address: m.kool@kitz-heidelberg.de.
Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE
Electronic Resource
Bleeker , G , van Eck-Smit , BL , Zwinderman , KH , Versteeg , R , Noesel , MM , Kam , BLR , Kaspers , GJ , van Schie , A , Kreissman , SG , Yanik , G , Hero , B , Schmidt , M , Laureys , G , Lambert , B , Ora , I , Schulte , JH , Caron , HN & Tytgat , GA 2015 , ' MIBG scans in patients with stage 4 neuroblastoma reveal two metastatic patterns, one is associated with MYCN amplification and in MYCN-amplified tumours correlates with a better prognosis ' , European Journal of Nuclear Medicine and Molecular Imaging , vol. 42 , no. 2 , pp. 222-230 .
Academic Journal
Vassal G; Institute Gustave Roussy, Université Paris Saclay, Villejuif, France. gilles.vassal@gustaveroussy.fr.; Houghton PJ; Greehey Children's Cancer Research Institute, UT Health, San Antonio, Texas.; Pfister SM; Hopp Children's Cancer Center Heidelberg (KiTZ), German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK) and University Hospital, Heidelberg, Germany.; Smith MA; Cancer Therapy Evaluation Program, National Cancer Institute, Bethesda, Maryland.; Caron HN; Hoffmann-La Roche, Basel, Switzerland.; Li XN; Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois.; Shields DJ; Pfizer Centers for Therapeutic Innovation, Pfizer Inc., New York, New York.; Witt O; Hopp Children's Cancer Center Heidelberg (KiTZ), German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK) and University Hospital, Heidelberg, Germany.; Molenaar JJ; Princess Máxima Centrum for Pediatric Oncology, Utrecht, The Netherlands.; Colombetti S; Hoffmann-La Roche, Basel, Switzerland.; Schüler J; Charles River Discovery Research Services Germany, Freiburg, Germany.; Stancato LF; Eli Lilly and Company, Indianapolis, Indiana.
Publisher: American Association for Cancer Research, Inc Country of Publication: United States NLM ID: 101132535 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1538-8514 (Electronic) Linking ISSN: 15357163 NLM ISO Abbreviation: Mol Cancer Ther Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[검색어] Caron, HN
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어